Topical hemostatic agents and dressings in the prehospital setting

Thomas E. Grissom, Raymond Fang

Research output: Contribution to journalReview article

Abstract

Purpose of review: Death from exsanguinating hemorrhage remains a priority in the management of combat casualties and civilian trauma patients with truncal and junctional injuries. Appropriate use of hemostatic agents and dressings in the prehospital setting may allow for earlier control and an improved survival rate. Recent findings: Third-generation chitosan-based hemostatic agents and dressings appear to be equally efficacious to the dressing currently deployed by the US military forces in the management of hemorrhage not amenable to tourniquet placement. Unfortunately, a lack of clinical trials places a heavy reliance on anecdotal reports and laboratory studies in agent selection and application. Summary: Efficacy of currently available hemostatic agents and dressings appears to have plateaued in recent years although new agents and delivery mechanisms under development may improve control in cases of severe hemorrhage.

Original languageEnglish (US)
Pages (from-to)210-216
Number of pages7
JournalCurrent Opinion in Anaesthesiology
Volume28
Issue number2
DOIs
StatePublished - Apr 7 2015
Externally publishedYes

Fingerprint

Hemostatics
Bandages
Hemorrhage
Exsanguination
Tourniquets
Wounds and Injuries
Chitosan
Survival Rate
Clinical Trials

Keywords

  • chitosan
  • emergency medical services
  • hemorrhage
  • hemostatics
  • military medicine

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Topical hemostatic agents and dressings in the prehospital setting. / Grissom, Thomas E.; Fang, Raymond.

In: Current Opinion in Anaesthesiology, Vol. 28, No. 2, 07.04.2015, p. 210-216.

Research output: Contribution to journalReview article

@article{f04507fe0cd44e1d81c37287dac1a802,
title = "Topical hemostatic agents and dressings in the prehospital setting",
abstract = "Purpose of review: Death from exsanguinating hemorrhage remains a priority in the management of combat casualties and civilian trauma patients with truncal and junctional injuries. Appropriate use of hemostatic agents and dressings in the prehospital setting may allow for earlier control and an improved survival rate. Recent findings: Third-generation chitosan-based hemostatic agents and dressings appear to be equally efficacious to the dressing currently deployed by the US military forces in the management of hemorrhage not amenable to tourniquet placement. Unfortunately, a lack of clinical trials places a heavy reliance on anecdotal reports and laboratory studies in agent selection and application. Summary: Efficacy of currently available hemostatic agents and dressings appears to have plateaued in recent years although new agents and delivery mechanisms under development may improve control in cases of severe hemorrhage.",
keywords = "chitosan, emergency medical services, hemorrhage, hemostatics, military medicine",
author = "Grissom, {Thomas E.} and Raymond Fang",
year = "2015",
month = "4",
day = "7",
doi = "10.1097/ACO.0000000000000166",
language = "English (US)",
volume = "28",
pages = "210--216",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Topical hemostatic agents and dressings in the prehospital setting

AU - Grissom, Thomas E.

AU - Fang, Raymond

PY - 2015/4/7

Y1 - 2015/4/7

N2 - Purpose of review: Death from exsanguinating hemorrhage remains a priority in the management of combat casualties and civilian trauma patients with truncal and junctional injuries. Appropriate use of hemostatic agents and dressings in the prehospital setting may allow for earlier control and an improved survival rate. Recent findings: Third-generation chitosan-based hemostatic agents and dressings appear to be equally efficacious to the dressing currently deployed by the US military forces in the management of hemorrhage not amenable to tourniquet placement. Unfortunately, a lack of clinical trials places a heavy reliance on anecdotal reports and laboratory studies in agent selection and application. Summary: Efficacy of currently available hemostatic agents and dressings appears to have plateaued in recent years although new agents and delivery mechanisms under development may improve control in cases of severe hemorrhage.

AB - Purpose of review: Death from exsanguinating hemorrhage remains a priority in the management of combat casualties and civilian trauma patients with truncal and junctional injuries. Appropriate use of hemostatic agents and dressings in the prehospital setting may allow for earlier control and an improved survival rate. Recent findings: Third-generation chitosan-based hemostatic agents and dressings appear to be equally efficacious to the dressing currently deployed by the US military forces in the management of hemorrhage not amenable to tourniquet placement. Unfortunately, a lack of clinical trials places a heavy reliance on anecdotal reports and laboratory studies in agent selection and application. Summary: Efficacy of currently available hemostatic agents and dressings appears to have plateaued in recent years although new agents and delivery mechanisms under development may improve control in cases of severe hemorrhage.

KW - chitosan

KW - emergency medical services

KW - hemorrhage

KW - hemostatics

KW - military medicine

UR - http://www.scopus.com/inward/record.url?scp=84926318644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926318644&partnerID=8YFLogxK

U2 - 10.1097/ACO.0000000000000166

DO - 10.1097/ACO.0000000000000166

M3 - Review article

C2 - 25674988

AN - SCOPUS:84926318644

VL - 28

SP - 210

EP - 216

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

IS - 2

ER -